East Tennessee Children's Hospital is a private, independent, not-for-profit, 152-bed pediatric medical center in Knoxville, Tennessee.

There are 152 beds in East Tennessee Childrens Hospital.

During the past decade, East Tennessee Childrens Hospital conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 68 clinical trials were completed, i.e. on average, 123.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Tennessee Childrens Hospital" #1 sponsor was "Children's Oncology Group" with 130 trials, followed by "National Cancer Institute (NCI)" with 58 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Tennessee Childrens Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "Children's Oncology Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "East Tennessee Childrens Hospital" are "Recurrent Neuroblastoma" (20 trials), "Recurrent Osteosarcoma" (17 trials), "Sarcoma" (16 trials), "Refractory Neuroblastoma" (14 trials) and "Neuroblastoma" (13 trials). Many other conditions were trialed in "East Tennessee Childrens Hospital" in a lesser frequency.

Most popular intervention types in "East Tennessee Childrens Hospital" are "Drug" (152 trials), "Other" (101 trials), "Procedure" (76 trials), "Biological" (72 trials) and "Radiation" (56 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Cyclophosphamide" (40 trials), "Vincristine Sulfate" (36 trials), "Etoposide" (28 trials) and "cyclophosphamide" (28 trials). Other intervention names were less common.

The vast majority of trials in "East Tennessee Childrens Hospital" are 196 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "East Tennessee Childrens Hospital". undefined are not yet recruiting, 38 are recruiting, 56 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in East Tennessee Childrens Hospital, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in East Tennessee Childrens Hospital, 7 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".